Provided by Tiger Trade Technology Pte. Ltd.

PDS Biotechnology Corporation

0.8991
+0.00901.01%
Post-market: 0.8705-0.0286-3.18%17:26 EST
Volume:595.67K
Turnover:527.65K
Market Cap:47.44M
PE:-1.10
High:0.9299
Open:0.8800
Low:0.8600
Close:0.8901
52wk High:2.20
52wk Low:0.7030
Shares:52.77M
Float Shares:51.41M
Volume Ratio:1.54
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8140
EPS(LYR):-1.0318
ROE:-221.81%
ROA:-46.22%
PB:5.02
PE(LYR):-0.87

Loading ...

MGOC Replacement PDS-MGO

Reuters
·
Dec 17

AASF Replacement PDS-AAS

Reuters
·
Dec 17

CitiFirst Single Stock MINIs Issue 15 Dec 25 PDS-CTW

Reuters
·
Dec 12

XASG Replacement PDS-XAS

Reuters
·
Dec 11

PDS Biotechnology Corp - Announces Japan Patent for PDS0101

THOMSON REUTERS
·
Dec 09

PDS Biotechnology Granted Broad Composition of Matter Patent for PDS0101 in Japan

Reuters
·
Dec 09

BRIEF-PDS Biotech Announces Scheduling Of Type C Meeting With U.S. Food And Drug Administration

Reuters
·
Dec 02

PDS Biotechnology Corp - Meeting to Discuss Accelerated Approval for PDS0101

THOMSON REUTERS
·
Dec 02

PDS Biotech Announces Scheduling of Type C Meeting With U.S. Food and Drug Administration (“FDA”)

THOMSON REUTERS
·
Dec 02

PRESS DIGEST- New York Times business news - December 2

Reuters
·
Dec 02

Analysts Offer Insights on Healthcare Companies: PDS Biotechnology (PDSB) and Autolus Therapeutics (AUTL)

TIPRANKS
·
Nov 14

PDS Biotechnology posts Q3 net loss of $9.0 million

Reuters
·
Nov 13

BRIEF-PDS Biotechnology Q3 EPS USD -0.19

Reuters
·
Nov 13

Press Release: PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update

Dow Jones
·
Nov 13

BRIEF-PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering

Reuters
·
Nov 12

PDS Biotechnology announces up to $11.1M registered direct offering

TIPRANKS
·
Nov 12

PDS Biotechnology Reports Positive Clinical Data for PDS0101 and PDS01ADC at SITC 2025

Reuters
·
Nov 10

BRIEF-PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer

Reuters
·
Oct 29

PIMCO SHORT TERM ACTIVE YIELD ACTIVE ETF PDS-EAR

Reuters
·
Oct 13

PDS Biotech: Achieves Extended Survival in Low Pd-L1 Expression Cohort in Versatile-002 Trial for Head & Neck Cancer, Possibly Removing Need for Chemo

THOMSON REUTERS
·
Sep 18